Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  DexCom, Inc.    DXCM

DEXCOM, INC. (DXCM)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/16/2018 02/20/2018 02/21/2018 02/22/2018 02/23/2018 Date
57.34(c) 57.13(c) 56.88(c) 56.4(c) 56.36(c) Last
639 336 823 019 1 048 029 713 144 703 013 Volume
+1.11% -0.37% -0.44% -0.84% -0.07% Change
More quotes
Financials ($)
Sales 2017 713 M
EBIT 2017 -48,4 M
Net income 2017 -46,7 M
Finance 2017 261 M
Yield 2017 -
Sales 2018 846 M
EBIT 2018 -19,5 M
Net income 2018 -36,8 M
Finance 2018 449 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 6,57x
EV / Sales2018 5,31x
Capitalization 4 943 M
More Financials
Company
DexCom, Inc. is a medical device manufacturing company, which engages in the design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes.Its products include Dexcom G4 PLATINUM System, Dexcom studio and Mobile apps.The company was... 
More about the company
Surperformance© ratings of DexCom, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on DEXCOM, INC.
02/12DEXCOM : Announces Upcoming Conference Presentations
BU
02/01DEXCOM SCHEDULES FOURTH QUARTER AND : 30 p.m. Eastern Time.
BU
01/26GLUCOSE MANAGEMENT SYSTEMS MARKET RE : Point-of-Care Genetic Testing Market Over..
AQ
01/09TANDEM DIABETES CARE REPORTS SUCCESS : slim X2 Insulin Pump with TypeZero Hybrid..
AQ
01/09DEXCOM INC : Results of Operations and Financial Condition, Regulation FD Disclo..
AQ
01/08DEXCOM INC : Results of Operations and Financial Condition, Financial Statements..
AQ
01/08DEXCOM : Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter an..
BU
2017DEXCOM : Announces Upcoming Conference Presentation
BU
2017DEXCOM : Raising funds for diabetes charities through social media
AQ
2017DEXCOM : Announces Development Agreement with Lilly to Integrate Dexcom CGM into..
AQ
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
02/23Legal hurdles, not Amazon, key concern for U.S. dental supply firms
RE
02/21OMAR ISHRAK : Pay if It Works -- WSJ
DJ
02/20MEDTRONIC : U.S. Revenue Drops -- Earnings Review
DJ
02/20MEDTRONIC MOVES TO A NEW HEALTH-CARE : Pay Only if It Works
DJ
02/15STRYKER : U.S. Regulators Extend Window for Critical Stroke Treatment
DJ
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
01:18aWant automatic email alerts for $DXCM $CCI $SNDE $YDKN $AMTX? Subscribe to Ma.. 
02/23DexCom, Inc. $DXCM Holdings Boosted by Wedbush Securities Inc.  
02/23DexCom, Inc. $DXCM Shares Sold by Swiss National Bank  
02/22Insider Selling: DexCom, Inc. $DXCM Chairman Sells 10,000 Shares of Stock  
02/21$DXCM New Form 4 for DexCom, Inc. From our Stock News Alerts App 
More tweets
Qtime:153
News from SeekingAlpha
01/09DexCom (DXCM) Presents At 36th Annual J.P. Morgan Healthcare Conference - Sli.. 
01/08DexCom sees $218M in Q4 sales 
01/04DexCom down 10% on Medicare coverage for Abbott's FreeStyle Libre CGM 
01/04HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am 
01/01Lean Long-Term Growth Portfolio - Year-End 2017 Update 
Chart DEXCOM, INC.
Duration : Period :
DexCom, Inc. Technical Analysis Chart | DXCM | US2521311074 | 4-Traders
Technical analysis trends DEXCOM, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 66,8 $
Spread / Average Target 17%
EPS Revisions
Managers
NameTitle
Kevin Ronald Sayer President, Chief Executive Officer & Director
Terrance H. Gregg Executive Chairman
Jeffrey C. Moy Senior Vice President-Operations
Quentin Blackford Chief Financial Officer
Jacob Leach Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
DEXCOM, INC.-1.73%4 943
MEDTRONIC PLC-0.42%109 254
BAXTER INTERNATIONAL4.32%36 531
ZIMMER BIOMET HOLDINGS-2.56%24 030
ALIGN TECHNOLOGY16.87%20 216
HOYA CORPORATION-6.17%19 502